Monepatel, why it has the upper hand. It is one of the unique molecules that passes through the BBB to treat neurodegenerative disorders. 100% of large molecules 98% small cannot. Not only Monepatel passes BBB we know it’s safety and tolerability due to prior approval. @IndexInvestor might find this interesting.
Just need liquid formulation (if same PK/PD as tablet formulation) may be considered same drug by FDA.
Ann: MND Trial Successfully Completes First Patient Cohort, page-157
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $95.68M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.5¢ | $85.59K | 405.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 188925 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 180688 | 3 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |